Unit of Physiopathology of Human Reproduction, Ospedale Policlinico San Martino, Genoa, Italy.
CNRS UMR7243, Université Paris-Dauphine, Paris, France.
Mol Hum Reprod. 2018 Jun 1;24(6):310-317. doi: 10.1093/molehr/gay018.
Does the presence of aggregates of smooth endoplasmic reticulum (SERa) impact the transcriptome of human metaphase II (MII) oocytes?.
The presence of SERa alters the molecular status of human metaphase II oocytes.
Oocytes presenting SERa are considered dysmorphic. Oocytes with SERa (SERa+) have been associated with reduced embryological outcome and increased risk of congenital anomalies, although some authors have reported that SERa+ oocytes can lead to healthy newborns. The question of whether or not SERa+ oocytes should be discarded is still open for debate, and no experimental information about the effect of the presence of SERa on the oocyte molecular status is available.
STUDY DESIGN, SIZE, DURATION: This study included 28 women, aged <38 years, without any ovarian pathology, and undergoing IVF treatment. Supernumerary MII oocytes with no sign of morphological alterations as well as SERa+ oocytes were donated after written informed consent. A total of 31 oocytes without SERa (SERa-) and 24 SERa+ oocytes were analyzed.
PARTICIPANTS/MATERIALS, SETTING, METHODS: Pools of 8-10 oocytes for both group were prepared. Total RNA was extracted from each pool, amplified, labeled and hybridized on oligonucleotide microarrays. Analyses were performed by R software using the limma package.
The expression profiles of SERa+ oocytes significantly differed from those of SERa- oocytes in 488 probe sets corresponding to 102 down-regulated and 283 up-regulated unique transcripts. Gene Ontology analysis by DAVID bioinformatics disclosed that genes involved in three main biological processes were significantly down-regulated in SERa+ oocytes respective to SERa- oocytes: (i) cell and mitotic/meiotic nuclear division, spindle assembly, chromosome partition and G2/M transition of mitotic cell cycle; (ii) organization of cytoskeleton and microtubules; and (iii) mitochondrial structure and activity. Among the transcripts up-regulated in SERa+ oocytes, the most significantly (P = 0.002) enriched GO term was 'GoLoco motif', including the RAP1GAP, GPSM3 and GPSM1 genes.
Raw microarray data are accessible through GEO Series accession number GSE106222 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE106222).
LIMITATIONS, REASONS FOR CAUTION: Data validation in a larger cohort of samples would be beneficial, although we applied stringent criteria for gene selection (fold-change >3 or <1/3 and FDR < 0.1). Surveys on clinical outcomes, malformation rates and follow-up of babies born after transfer of embryos from SERa+ oocytes are necessary.
We provide information on the molecular status of SERa+ oocytes, highlighting possible associations between presence of SERa, altered oocyte physiology and reduced developmental competence. Our study may offer further information that can assist embryologists to make decisions on whether, and with what possible implications, SERa+ oocytes should be used. We believe that the presence of SERa should be still a 'red flag' in IVF practices and that the decision to inseminate SERa+ oocytes should be discussed on a case-by-case basis.
STUDY FUNDING/COMPETING INTEREST(S): This study was partially supported by Ferring Pharmaceuticals. The authors have no conflicts of interest to declare.
内质网(SER)的聚集是否会影响人类中期 II(MII)卵母细胞的转录组?
内质网聚集改变了人类中期 II 卵母细胞的分子状态。
被认为是畸形的卵母细胞存在 SERa。虽然一些作者报告说 SERa+卵母细胞可以导致健康的新生儿,但具有 SERa(SERa+)的卵母细胞与胚胎发育结果降低和先天畸形风险增加有关。关于是否应该丢弃 SERa+卵母细胞的问题仍存在争议,并且没有关于 SERa 存在对卵母细胞分子状态影响的实验信息。
研究设计、大小、持续时间:这项研究包括 28 名年龄<38 岁、无任何卵巢病理且接受 IVF 治疗的女性。在书面知情同意后,捐赠了没有形态改变迹象的多余 MII 卵母细胞和 SERa+卵母细胞。分析了 31 个没有 SERa(SERa-)的卵母细胞和 24 个 SERa+卵母细胞。
参与者/材料、设置、方法:每组 8-10 个卵母细胞进行混合。从每个卵母细胞中提取总 RNA,进行扩增、标记和寡核苷酸微阵列杂交。使用 R 软件中的 limma 包进行分析。
SERa+卵母细胞的表达谱与 SERa-卵母细胞的表达谱在对应于 102 个下调和 283 个上调独特转录物的 488 个探针集中显著不同。通过 DAVID 生物信息学进行的基因本体论分析表明,SERa+卵母细胞中参与三个主要生物学过程的基因显著下调:(i)细胞和有丝分裂/减数分裂核分裂、纺锤体组装、染色体分离和有丝分裂细胞周期的 G2/M 转换;(ii)细胞骨架和微管的组织;和(iii)线粒体结构和活性。在上调的转录物中,最显著(P=0.002)富集的 GO 术语是“GoLoco 基序”,包括 RAP1GAP、GPSM3 和 GPSM1 基因。
原始微阵列数据可通过 GEO 系列注册号 GSE106222(https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE106222)获得。
局限性、谨慎的原因:尽管我们应用了严格的基因选择标准(倍数变化>3 或 <1/3 和 FDR < 0.1),但在更大样本量的样本中进行数据验证将是有益的。需要对临床结局、畸形率和从 SERa+卵母细胞转移的胚胎的婴儿随访进行调查。
我们提供了 SERa+卵母细胞分子状态的信息,突出了 SERa 的存在、卵母细胞生理学改变和发育能力降低之间可能存在的关联。我们的研究可能提供了更多的信息,可以帮助胚胎学家决定是否以及可能存在哪些影响使用 SERa+卵母细胞。我们认为,SERa 的存在仍然是 IVF 实践中的“红旗”,并且应该根据具体情况讨论使用 SERa+卵母细胞的决定。
研究资金/利益冲突:这项研究部分得到了 Ferring 制药公司的支持。作者没有利益冲突要声明。